Anabel Gil

818 citations
17 papers · 669 indexed · h-index 11
Topics
PI3K/AKT/mTOR signaling in cancer (9 papers)Protein Kinase Regulation and GTPase Signaling (3 papers)Influenza Virus Research Studies (2 papers)
Partner nations
SpainCanadaMongolia

In The Last Decade

Anabel Gil

17 papers receiving 661 citations

Peers

Anabel Gil
Comparison fields: 5 of 86
  • Molecular Biology 485
  • Oncology 95
  • Cell Biology 77
  • Epidemiology 70
  • Immunology 70
Replace Daniel Fernández-Pérez with:
Daniel Fernández-Pérez Italy
Miho Oyasu Japan
Mamiko Sukeno Japan
Timothy A. Bolger United States
Yiyuan Liu China
Anaïs Wanet Belgium
Katarzyna M. Wilczynska United States
Varda Oron‐Karni Israel
Hiromi Takanaga Japan
Anabel Gil relative to Daniel Fernández-Pérez Italy Daniel Fernández-Pérez's profile →
Citations per field
00.5×10×15.5×
Daniel Fernández-Pérez · 1×
Citations per year

Countries citing papers authored by Anabel Gil

Since Specialization
Citations

This map shows the geographic impact of Anabel Gil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anabel Gil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anabel Gil more than expected).

Fields of papers citing papers by Anabel Gil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anabel Gil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anabel Gil. The network helps show where Anabel Gil may publish in the future.

Co-authorship network of co-authors of Anabel Gil

This figure shows the co-authorship network connecting the top 25 collaborators of Anabel Gil. A scholar is included among the top collaborators of Anabel Gil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anabel Gil. Anabel Gil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 2
2 2
3 38
4 41
5 9
6 9
7 26
8 62
9 63
10 36
11 23
12 35
13 117
14 181
15 17
16 4
17 4

About Anabel Gil

Anabel Gil is a scholar working on Behavioral Neuroscience, Industrial and Manufacturing Engineering and Genetics, having authored 17 papers that have together received 669 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (9 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Influenza Virus Research Studies (2 papers). The work is most often cited by research in Biological Psychiatry (26 citations), Molecular Biology (485 citations) and Genetics (69 citations). Anabel Gil has collaborated with scholars based in Spain, Canada and Mongolia. Frequent co-authors include Rafael Pulido, Miguel Valiente, Amparo Andrés‐Pons, Josema Torres, Stylianos E. Antonarakis, Caroline Tapparel, Javier Lizardi Cervera, Elena Fernández Fernández, Consuelo Guerri and Jorge Montesinos. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026